| Autor: |
Shinde R; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Immunology, University of Toronto, Toronto, ON, Canada., Hezaveh K; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Immunology, University of Toronto, Toronto, ON, Canada., Halaby MJ; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Immunology, University of Toronto, Toronto, ON, Canada., Kloetgen A; Department of Pathology, New York University School of Medicine, New York, NY, USA., Chakravarthy A; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., da Silva Medina T; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Deol R; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Manion KP; Department of Immunology, University of Toronto, Toronto, ON, Canada.; Krembil Research Institute, University Health Network, Toronto, ON, Canada., Baglaenko Y; Department of Immunology, University of Toronto, Toronto, ON, Canada.; Krembil Research Institute, University Health Network, Toronto, ON, Canada., Eldh M; Department of Medicine, Unit for Immunology and Allergy, Karolinska Institute, Stockholm, Sweden., Lamorte S; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Immunology, University of Toronto, Toronto, ON, Canada., Wallace D; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Chodisetti SB; Department of Immunology, Pennsylvania State University School of Medicine, Hershey, PA, USA., Ravishankar B; Department of Cancer Immunology, Genentech, San Francisco, CA, USA., Liu H; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Chaudhary K; Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Munn DH; Department of Paediatrics, Medical College of Georgia, Augusta, GA, USA., Tsirigos A; Department of Pathology, New York University School of Medicine, New York, NY, USA.; Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY, USA.; Applied Bioinformatics Laboratories, New York University School of Medicine, New York, NY, USA., Madaio M; Department of Medicine, Medical College of Georgia, Augusta, GA, USA., Gabrielsson S; Department of Medicine, Unit for Immunology and Allergy, Karolinska Institute, Stockholm, Sweden., Touma Z; University of Toronto Lupus Clinic, University of Toronto, Toronto, ON, Canada.; Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada., Wither J; Department of Immunology, University of Toronto, Toronto, ON, Canada.; Krembil Research Institute, University Health Network, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada., De Carvalho DD; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., McGaha TL; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. tmcgaha@uhnresearch.ca.; Department of Immunology, University of Toronto, Toronto, ON, Canada. tmcgaha@uhnresearch.ca. |
Full text from SpringerLink